Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-19

Clinical Trial Update: Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Roxadustat in anemia associated with chronic kidney disease not requiring dialysis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: Chronic Kidney Disease, Anemia | Phase 2 | Status: COMPLETED | Results posted: 2021-11-19